Fabian Echterdiek
Research Subjects
Fabian Echterdiek has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Vedat Schwenger
Department of Nephrology Klinikum Stuttgart -Katharinenhospital Stuttgart Germany
11 shared publicationsDaniel Kitterer
Department of Nephrology Klinikum Stuttgart – Katharinenhospital Stuttgart Germany
6 shared publicationsJoerg Latus
Department of Nephrology Klinikum Stuttgart – Katharinenhospital Stuttgart Germany
6 shared publications- Joerg Latus
Department of Internal Medicine and Nephrology, Robert Bosch Hospital Stuttgart, Auerbachstr. 110, 70376 Stuttgart, Germany
4 shared publications Jürgen Dippon
Institute for Stochastics and Applications, University of Stuttgart
4 shared publicationsBernd Döhler
Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany
3 shared publications
Latest Publications
- Open Access
- 21 January 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1683082
Impact of acute kidney injury in ≥65-year-old kidney donors on short- and long-term allograft outcomes
Background: Kidney transplantation (KT) from elderly donors (aged ≥65 years) with acute kidney injury (AKI) remains controversial and these organs might be underutilized. To date, clear evidence supporting the safety of KT from donors with AKI exists solely for younger donor populations. We hypothesized that, when appropriately selected, graft survival and function in recipients of kidneys from AKI and non-AKI donors aged ≥65 years are comparable. Methods: We conducted a retrospective cohort study analyzing KT outcomes from donors aged ≥65 years with and without AKI that were performed between 2006 and 2021 at three German transplant centers. AKI was defined according to KDIGO criteria. Death-censored graft survival, overall graft survival, patient survival up to 7 years, eGFR up to 5 years as well as incidence of delayed graft function and biopsy proven acute rejection were compared. Kaplan-Meier analyses and multivariable Cox regression were performed. Results: Of 685 KT recipients, 183 received kidneys from AKI donors, and 502 from non-AKI donors. Most KTs were from donors with KDIGO stage 1 AKI ( n = 151; 81.6%). Delayed graft function occurred similarly often in AKI and non-AKI recipients (32.8% vs. 32.8%, p = 1.0). Death-censored graft survival was comparable between AKI and non-AKI groups (7 years: 59.0% vs. 61.3%; p = 0.87). Median eGFR at 12 months was 33.8 mL/min/1.73 m 2 (IQR 27.3, 44.2) in the AKI group and 35.5 mL/min/1.73 m 2 (IQR 26.3, 44.8) in the non-AKI group ( p = 0.79). These results remained unchanged after adjustment for known risk factors of graft survival in the multivariable Cox regression. Conclusion: In this study, KT from ≥65-year-old donors with mostly mild AKI resulted in similar short and long-term graft survival and function compared to KT from ≥65-year-old donors without AKI. These findings support the utilization of AKI kidneys from elderly donors to expand the donor pool without compromising outcomes.
- 21 January 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1683082
Open AccessImpact of acute kidney injury in ≥65-year-old kidney donors on short- and long-term allograft outcomes
Background: Kidney transplantation (KT) from elderly donors (aged ≥65 years) with acute kidney injury (AKI) remains controversial and these organs might be underutilized. To date, clear evidence supporting the safety of KT from donors with AKI exists solely for younger donor populations. We hypothesized that, when appropriately selected, graft survival and function in recipients of kidneys from AKI and non-AKI donors aged ≥65 years are comparable. Methods: We conducted a retrospective cohort study analyzing KT outcomes from donors aged ≥65 years with and without AKI that were performed between 2006 and 2021 at three German transplant centers. AKI was defined according to KDIGO criteria. Death-censored graft survival, overall graft survival, patient survival up to 7 years, eGFR up to 5 years as well as incidence of delayed graft function and biopsy proven acute rejection were compared. Kaplan-Meier analyses and multivariable Cox regression were performed. Results: Of 685 KT recipients, 183 received kidneys from AKI donors, and 502 from non-AKI donors. Most KTs were from donors with KDIGO stage 1 AKI ( n = 151; 81.6%). Delayed graft function occurred similarly often in AKI and non-AKI recipients (32.8% vs. 32.8%, p = 1.0). Death-censored graft survival was comparable between AKI and non-AKI groups (7 years: 59.0% vs. 61.3%; p = 0.87). Median eGFR at 12 months was 33.8 mL/min/1.73 m 2 (IQR 27.3, 44.2) in the AKI group and 35.5 mL/min/1.73 m 2 (IQR 26.3, 44.8) in the non-AKI group ( p = 0.79). These results remained unchanged after adjustment for known risk factors of graft survival in the multivariable Cox regression. Conclusion: In this study, KT from ≥65-year-old donors with mostly mild AKI resulted in similar short and long-term graft survival and function compared to KT from ≥65-year-old donors without AKI. These findings support the utilization of AKI kidneys from elderly donors to expand the donor pool without compromising outcomes.
- Open Access
- 14 February 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (7) , e41528
CO2 and aerosol concentration during manual and mechanical chest compression while cardiopulmonary resuscitation
Background: This study investigates the staff-to-staff transmission risk of Coronavirus disease 2019 during cardiopulmonary resuscitation in an ambulance vehicle. Methods: Comparing manual and mechanical chest compressions, CO2 concentrations were monitored as a proxy for infection risk. Results: Results suggest that mechanical chest compressions generate lower CO2 levels, indicating a reduced risk of infection among healthcare workers compared to manual compressions. Conclusions: These findings highlight the potential benefits of employing mechanical chest compressions to mitigate staff-to-staff infections in small, confined spaces during aerosol-transmitted diseases.
- 14 February 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (7) , e41528
Open AccessCO2 and aerosol concentration during manual and mechanical chest compression while cardiopulmonary resuscitation
Background: This study investigates the staff-to-staff transmission risk of Coronavirus disease 2019 during cardiopulmonary resuscitation in an ambulance vehicle. Methods: Comparing manual and mechanical chest compressions, CO2 concentrations were monitored as a proxy for infection risk. Results: Results suggest that mechanical chest compressions generate lower CO2 levels, indicating a reduced risk of infection among healthcare workers compared to manual compressions. Conclusions: These findings highlight the potential benefits of employing mechanical chest compressions to mitigate staff-to-staff infections in small, confined spaces during aerosol-transmitted diseases.
- 24 August 2022
- Published by Springer Nature in Wiener klinisches Magazin
- p. 1-6
Peritonealdialyse bei therapierefraktärer Herzinsuffizienz und Leberzirrhose
- 24 August 2022
- Published by Springer Nature in Wiener klinisches Magazin
- p. 1-6
Peritonealdialyse bei therapierefraktärer Herzinsuffizienz und Leberzirrhose
- 23 June 2022
- Published by Springer Nature in Pediatric Nephrology
- Vol. 37 (12) , 3031-3042
Kidney disease and thyroid dysfunction: the chicken or egg problem
Patients with non-dialysis-dependant chronic kidney disease (NDD-CKD) and dialysis-dependant chronic kidney disease (DD-CKD) frequently also suffer from thyroid disorders, especially hypothyroidism which is found two to five times more often among them compared to the general population. Emerging research has illustrated the potential prognostic implications of this association as NDD-CKD and DD-CKD patients with hypothyroidism have been shown to have higher mortality rates, and treatment of subclinical hypothyroidism in NDD-CKD patients has been reported to attenuate the decline of glomerular filtration rate over time. This review illustrates the bidirectional, multi-layered interplay between the kidneys and the thyroid gland explaining how pathologies in one organ will affect the other and vice versa. Additionally, it outlines the impact of thyroid disorders on routine parameters of kidney function (especially serum creatinine and serum cystatin C) that nephrologists should be aware of in their clinical practice. Lastly, it summarizes the emerging evidence from clinical studies on how treatment of subclinical hypothyroidism in NDD-CKD and DD-CKD patients may potentially have beneficial effects on kidney function as well as mortality. While most of the research in this area has been performed on adult patients, we specifically discuss what is currently known about thyroid dysfunctions in paediatric CKD patients as well and provide management suggestions. The evidence accumulated so far clearly indicates that further, prospective studies with meticulous methodology are warranted to refine our understanding of thyroid disorders in paediatric and adult CKD patients and establish optimal treatment pathways.
- 23 June 2022
- Published by Springer Nature in Pediatric Nephrology
- Vol. 37 (12) , 3031-3042
Kidney disease and thyroid dysfunction: the chicken or egg problem
Patients with non-dialysis-dependant chronic kidney disease (NDD-CKD) and dialysis-dependant chronic kidney disease (DD-CKD) frequently also suffer from thyroid disorders, especially hypothyroidism which is found two to five times more often among them compared to the general population. Emerging research has illustrated the potential prognostic implications of this association as NDD-CKD and DD-CKD patients with hypothyroidism have been shown to have higher mortality rates, and treatment of subclinical hypothyroidism in NDD-CKD patients has been reported to attenuate the decline of glomerular filtration rate over time. This review illustrates the bidirectional, multi-layered interplay between the kidneys and the thyroid gland explaining how pathologies in one organ will affect the other and vice versa. Additionally, it outlines the impact of thyroid disorders on routine parameters of kidney function (especially serum creatinine and serum cystatin C) that nephrologists should be aware of in their clinical practice. Lastly, it summarizes the emerging evidence from clinical studies on how treatment of subclinical hypothyroidism in NDD-CKD and DD-CKD patients may potentially have beneficial effects on kidney function as well as mortality. While most of the research in this area has been performed on adult patients, we specifically discuss what is currently known about thyroid dysfunctions in paediatric CKD patients as well and provide management suggestions. The evidence accumulated so far clearly indicates that further, prospective studies with meticulous methodology are warranted to refine our understanding of thyroid disorders in paediatric and adult CKD patients and establish optimal treatment pathways.
- 11 February 2022
- Published by Wiley in Clinical Transplantation
- Vol. 36 (5) , e14612
Outcome of kidney transplantations from ≥65‐year‐old deceased donors with acute kidney injury
Kidney transplantation (KT) from donors with acute kidney injury (AKI) has been associated with delayed graft function (DGF) but similar graft survival compared with KT from donors without AKI. Kidneys from ≥65‐year‐old donors with comorbidities are more susceptible to cold ischemia time (CIT) and DGF and it is unknown whether such elderly kidneys with AKI can also be transplanted with satisfactory outcomes.All KTs from ≥65‐year‐old donors performed at our center from 1999 to 2019 (n = 233) were retrospectively analyzed and short‐ as well as long‐term outcomes were compared for KTs from donors with (n = 64) and without AKI (n = 169).There were no significant differences regarding the frequency of DGF as well as the estimated glomerular filtration rate (eGFR) 1 and 3 years post‐transplant between the no‐AKI and the AKI group (DGF: no‐AKI 30.2% vs. AKI 40.6%, P = .17; eGFR at 1‐year: 31.9 ml/min/1.73 m2 vs. 35.5 ml/min/1.73 m2, P = .32; at 3‐years: 33.8 ml/min/1.73 m2 vs. 40.9 ml/min/1.73 m2, P = .18; respectively). Death‐censored graft survival and patient survival were also not significantly different. Multivariable Cox regression analysis did not identify AKI as a significant risk factor for graft loss or death.Following careful donor and recipient selection, kidneys from ≥65‐year‐old AKI donors may potentially be transplanted with satisfactory outcomes.
- 11 February 2022
- Published by Wiley in Clinical Transplantation
- Vol. 36 (5) , e14612
Outcome of kidney transplantations from ≥65‐year‐old deceased donors with acute kidney injury
Kidney transplantation (KT) from donors with acute kidney injury (AKI) has been associated with delayed graft function (DGF) but similar graft survival compared with KT from donors without AKI. Kidneys from ≥65‐year‐old donors with comorbidities are more susceptible to cold ischemia time (CIT) and DGF and it is unknown whether such elderly kidneys with AKI can also be transplanted with satisfactory outcomes.All KTs from ≥65‐year‐old donors performed at our center from 1999 to 2019 (n = 233) were retrospectively analyzed and short‐ as well as long‐term outcomes were compared for KTs from donors with (n = 64) and without AKI (n = 169).There were no significant differences regarding the frequency of DGF as well as the estimated glomerular filtration rate (eGFR) 1 and 3 years post‐transplant between the no‐AKI and the AKI group (DGF: no‐AKI 30.2% vs. AKI 40.6%, P = .17; eGFR at 1‐year: 31.9 ml/min/1.73 m2 vs. 35.5 ml/min/1.73 m2, P = .32; at 3‐years: 33.8 ml/min/1.73 m2 vs. 40.9 ml/min/1.73 m2, P = .18; respectively). Death‐censored graft survival and patient survival were also not significantly different. Multivariable Cox regression analysis did not identify AKI as a significant risk factor for graft loss or death.Following careful donor and recipient selection, kidneys from ≥65‐year‐old AKI donors may potentially be transplanted with satisfactory outcomes.
- Open Access
- 7 February 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (2) , e28199
Improving Emergency Department Patient-Physician Conversation Through an Artificial Intelligence Symptom-Taking Tool: Mixed Methods Pilot Observational Study
Background: Establishing rapport and empathy between patients and their health care provider is important but challenging in the context of a busy and crowded emergency department (ED). Objective: We explore the hypotheses that rapport building, documentation, and time efficiency might be improved in the ED by providing patients a digital tool that uses Bayesian reasoning–based techniques to gather relevant symptoms and history for handover to clinicians. Methods: A 2-phase pilot evaluation was carried out in the ED of a German tertiary referral and major trauma hospital that treats an average of 120 patients daily. Phase 1 observations guided iterative improvement of the digital tool, which was then further evaluated in phase 2. All patients who were willing and able to provide consent were invited to participate, excluding those with severe injury or illness requiring immediate treatment, with traumatic injury, incapable of completing a health assessment, and aged <18 years. Over an 18-day period with 1699 patients presenting to the ED, 815 (47.96%) were eligible based on triage level. With available recruitment staff, 135 were approached, of whom 81 (60%) were included in the study. In a mixed methods evaluation, patients entered information into the tool, accessed by clinicians through a dashboard. All users completed evaluation Likert-scale questionnaires rating the tool’s performance. The feasibility of a larger trial was evaluated through rates of recruitment and questionnaire completion. Results: Respondents strongly endorsed the tool for facilitating conversation (61/81, 75% of patients, 57/78, 73% of physician ratings, and 10/10, 100% of nurse ratings). Most nurses judged the tool as potentially time saving, whereas most physicians only agreed for a subset of medical specialties (eg, surgery). Patients reported high usability and understood the tool’s questions. The tool was recommended by most patients (63/81, 78%), in 53% (41/77) of physician ratings, and in 76% (61/80) of nurse ratings. Questionnaire completion rates were 100% (81/81) by patients and 96% (78/81 enrolled patients) by physicians. Conclusions: This pilot confirmed that a larger study in the setting would be feasible. The tool has clear potential to improve patient–health care provider interaction and could also contribute to ED efficiency savings. Future research and development will extend the range of patients for whom the history-taking tool has clinical utility. Trial Registration: German Clinical Trials Register DRKS00024115; https://drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024115
- 7 February 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (2) , e28199
Open AccessImproving Emergency Department Patient-Physician Conversation Through an Artificial Intelligence Symptom-Taking Tool: Mixed Methods Pilot Observational Study
Background: Establishing rapport and empathy between patients and their health care provider is important but challenging in the context of a busy and crowded emergency department (ED). Objective: We explore the hypotheses that rapport building, documentation, and time efficiency might be improved in the ED by providing patients a digital tool that uses Bayesian reasoning–based techniques to gather relevant symptoms and history for handover to clinicians. Methods: A 2-phase pilot evaluation was carried out in the ED of a German tertiary referral and major trauma hospital that treats an average of 120 patients daily. Phase 1 observations guided iterative improvement of the digital tool, which was then further evaluated in phase 2. All patients who were willing and able to provide consent were invited to participate, excluding those with severe injury or illness requiring immediate treatment, with traumatic injury, incapable of completing a health assessment, and aged <18 years. Over an 18-day period with 1699 patients presenting to the ED, 815 (47.96%) were eligible based on triage level. With available recruitment staff, 135 were approached, of whom 81 (60%) were included in the study. In a mixed methods evaluation, patients entered information into the tool, accessed by clinicians through a dashboard. All users completed evaluation Likert-scale questionnaires rating the tool’s performance. The feasibility of a larger trial was evaluated through rates of recruitment and questionnaire completion. Results: Respondents strongly endorsed the tool for facilitating conversation (61/81, 75% of patients, 57/78, 73% of physician ratings, and 10/10, 100% of nurse ratings). Most nurses judged the tool as potentially time saving, whereas most physicians only agreed for a subset of medical specialties (eg, surgery). Patients reported high usability and understood the tool’s questions. The tool was recommended by most patients (63/81, 78%), in 53% (41/77) of physician ratings, and in 76% (61/80) of nurse ratings. Questionnaire completion rates were 100% (81/81) by patients and 96% (78/81 enrolled patients) by physicians. Conclusions: This pilot confirmed that a larger study in the setting would be feasible. The tool has clear potential to improve patient–health care provider interaction and could also contribute to ED efficiency savings. Future research and development will extend the range of patients for whom the history-taking tool has clinical utility. Trial Registration: German Clinical Trials Register DRKS00024115; https://drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024115
- 18 January 2022
- Published by Wolters Kluwer Health in Transplantation
- Vol. 106 (4) , e212-e218
Influence of Calcineurin Inhibitor Choice on Outcomes in Kidney Transplant Recipients Aged ≥60 Y: A Collaborative Transplant Study Report
Background.: Patients aged ≥60 y represent the fastest growing population among kidney transplant recipients and waitlist patients. They show an elevated infection risk and are frequently transplanted with multiple human leukocyte antigen mismatches. Whether the choice of calcineurin inhibitor influences graft survival, mortality, or key secondary outcomes such as infections in this vulnerable recipient population is unknown. Methods.: A total of 31 177 kidney transplants from deceased donors performed between 2000 and 2019 at European centers and reported to the Collaborative Transplant Study were analyzed using multivariable Cox and logistic regression analyses. All recipients were ≥60 y old and received tacrolimus (Tac) or cyclosporine A on an intention-to-treat basis, combined with mycophenolic acid or azathioprine plus/minus steroids. Results.: The risk of 3-y death-censored graft loss and patient mortality did not differ significantly between Tac- and cyclosporine A-treated patients (hazard ratio 0.98 and 0.95, P = 0.74 and 0.20, respectively). No difference was found in the overall risk of hospitalization for infection (hazard ratio = 0.95, P = 0.19); however, a lower incidence of rejection treatment (hazard ratio = 0.81, P < 0.001) was observed in Tac-treated patients. Assessment of pathogen-specific hospitalizations revealed no difference in the risk of hospitalization due to bacterial infection (odds ratio = 1.00, P = 0.96), but a significantly higher risk of hospitalization due to human polyomavirus infection was found among Tac-treated patients (odds ratio = 2.45, P = 0.002). The incidence of de novo diabetes was higher for Tac-based immunosuppression (odds ratio = 1.79, P < 0.001). Conclusions.: Calcineurin inhibitor selection has no significant influence on death-censored graft survival, mortality, and overall infection risk in ≥60-y-old kidney transplant recipients.
- 18 January 2022
- Published by Wolters Kluwer Health in Transplantation
- Vol. 106 (4) , e212-e218
Influence of Calcineurin Inhibitor Choice on Outcomes in Kidney Transplant Recipients Aged ≥60 Y: A Collaborative Transplant Study Report
Background.: Patients aged ≥60 y represent the fastest growing population among kidney transplant recipients and waitlist patients. They show an elevated infection risk and are frequently transplanted with multiple human leukocyte antigen mismatches. Whether the choice of calcineurin inhibitor influences graft survival, mortality, or key secondary outcomes such as infections in this vulnerable recipient population is unknown. Methods.: A total of 31 177 kidney transplants from deceased donors performed between 2000 and 2019 at European centers and reported to the Collaborative Transplant Study were analyzed using multivariable Cox and logistic regression analyses. All recipients were ≥60 y old and received tacrolimus (Tac) or cyclosporine A on an intention-to-treat basis, combined with mycophenolic acid or azathioprine plus/minus steroids. Results.: The risk of 3-y death-censored graft loss and patient mortality did not differ significantly between Tac- and cyclosporine A-treated patients (hazard ratio 0.98 and 0.95, P = 0.74 and 0.20, respectively). No difference was found in the overall risk of hospitalization for infection (hazard ratio = 0.95, P = 0.19); however, a lower incidence of rejection treatment (hazard ratio = 0.81, P < 0.001) was observed in Tac-treated patients. Assessment of pathogen-specific hospitalizations revealed no difference in the risk of hospitalization due to bacterial infection (odds ratio = 1.00, P = 0.96), but a significantly higher risk of hospitalization due to human polyomavirus infection was found among Tac-treated patients (odds ratio = 2.45, P = 0.002). The incidence of de novo diabetes was higher for Tac-based immunosuppression (odds ratio = 1.79, P < 0.001). Conclusions.: Calcineurin inhibitor selection has no significant influence on death-censored graft survival, mortality, and overall infection risk in ≥60-y-old kidney transplant recipients.
- 26 November 2021
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 407 (2) , 727-737
Impact of the explanting surgeon’s impression of donor arteriosclerosis on outcome of kidney transplantations from donors aged ≥65 years
Purpose Careful donor selection is important for kidney transplantations (KT) from suboptimal donors aged ≥65 years. Several tools such as histopathological assessment of preimplant biopsies have been shown to predict allograft survival and can be applied for selection. Whether the explanting surgeon’s appraisal is associated with outcomes of KTs from suboptimal donors is unknown. Methods We compared outcomes of KTs from ≥65-year-old deceased donors performed at our centre between 1999 and 2018 for which grading of macroscopic ‘donor arteriosclerosis’ (n=104) and ‘organ quality’ (n=208) as judged by the explanting surgeon and documented on the Eurotransplant kidney organ report was available. Results No association was observed between degree of macroscopic donor arteriosclerosis and death-censored graft survival in univariable or multivariable regression analyses. Compared to KTs from donors with no/mild arteriosclerosis, KTs from donors with moderate/severe arteriosclerosis were associated with a significantly impaired allograft function 3 months, 1 year and 3 years after transplantation (e.g. at 3 years: 176.8 µmol/l vs 137.0 µmol/l, P=0.003). Following multivariable regression analysis, these differences remained significant at 3 months and 3 years after KT. No association was observed between degree of macroscopic arteriosclerosis and mortality or primary non-function as well as no consistent association with delayed graft function and histological arteriosclerosis. Assessment of ‘organ quality’ was not associated with outcomes. Conclusion Our data suggest that the explanting surgeon’s assessment of donor arteriosclerosis is associated with allograft function. Larger studies and better standardization of kidney inspection after explantation are required to further explore the impact of surgeon’s appraisal in KT.
- 26 November 2021
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 407 (2) , 727-737
Impact of the explanting surgeon’s impression of donor arteriosclerosis on outcome of kidney transplantations from donors aged ≥65 years
Purpose Careful donor selection is important for kidney transplantations (KT) from suboptimal donors aged ≥65 years. Several tools such as histopathological assessment of preimplant biopsies have been shown to predict allograft survival and can be applied for selection. Whether the explanting surgeon’s appraisal is associated with outcomes of KTs from suboptimal donors is unknown. Methods We compared outcomes of KTs from ≥65-year-old deceased donors performed at our centre between 1999 and 2018 for which grading of macroscopic ‘donor arteriosclerosis’ (n=104) and ‘organ quality’ (n=208) as judged by the explanting surgeon and documented on the Eurotransplant kidney organ report was available. Results No association was observed between degree of macroscopic donor arteriosclerosis and death-censored graft survival in univariable or multivariable regression analyses. Compared to KTs from donors with no/mild arteriosclerosis, KTs from donors with moderate/severe arteriosclerosis were associated with a significantly impaired allograft function 3 months, 1 year and 3 years after transplantation (e.g. at 3 years: 176.8 µmol/l vs 137.0 µmol/l, P=0.003). Following multivariable regression analysis, these differences remained significant at 3 months and 3 years after KT. No association was observed between degree of macroscopic arteriosclerosis and mortality or primary non-function as well as no consistent association with delayed graft function and histological arteriosclerosis. Assessment of ‘organ quality’ was not associated with outcomes. Conclusion Our data suggest that the explanting surgeon’s assessment of donor arteriosclerosis is associated with allograft function. Larger studies and better standardization of kidney inspection after explantation are required to further explore the impact of surgeon’s appraisal in KT.
- 24 September 2021
- Published by Springer Nature in Der Nephrologe
- Vol. 17 (2) , 92-97
Peritonealdialyse bei therapierefraktärer Herzinsuffizienz und Leberzirrhose
- 24 September 2021
- Published by Springer Nature in Der Nephrologe
- Vol. 17 (2) , 92-97
Peritonealdialyse bei therapierefraktärer Herzinsuffizienz und Leberzirrhose
- 13 August 2021
- Published by Wiley in Clinical Transplantation
- Vol. 35 (11) , e14452
Impact of cardiopulmonary resuscitation on outcome of kidney transplantations from braindead donors aged ≥65 years
Introduction: Patients with a history of cardiopulmonary resuscitation (CPR) and subsequent brain death are frequently evaluated for organ donation. Whether kidneys from ≥65‐year‐old braindead donors with a history of CPR can be transplanted with satisfactory outcomes is unknown.Material & Methods: All kidney transplants (KTs) from ≥65‐year‐old donors performed at our center from 1999 to 2018 (n = 185) were retrospectively analyzed and outcome was compared for KTs from donors with and without a history of CPR (n = 27 and n = 158, respectively).Results: No significant differences in the incidence of delayed graft function (DGF) as well as 1‐ and 3‐year graft function were observed between the CPR and the no‐CPR group (DGF: 26.0% vs. 31.0%, p = .76; 1‐year serum creatinine: 150.4 μmol/L vs. 177.0 μmol/L, p = .11; 3‐year serum creatinine: 150.4 μmol/L vs. 168.2 μmol/L, p = .52, respectively). Death‐censored graft survival was comparable after 1 and 5 years (CPR group: 81.5% and 76.7% vs. no‐CPR group: 86.6% and 75.7%, p = .70). Likewise, patient survival was not significantly different. Multivariable Cox regression analysis also did not identify CPR as a significant risk factor for graft loss or death.Conclusion: Our study suggests that, following stringent donor selection, the outcome of KTs from ≥65‐year‐old braindead donors with and without a history of CPR is comparable.
- 13 August 2021
- Published by Wiley in Clinical Transplantation
- Vol. 35 (11) , e14452
Impact of cardiopulmonary resuscitation on outcome of kidney transplantations from braindead donors aged ≥65 years
Introduction: Patients with a history of cardiopulmonary resuscitation (CPR) and subsequent brain death are frequently evaluated for organ donation. Whether kidneys from ≥65‐year‐old braindead donors with a history of CPR can be transplanted with satisfactory outcomes is unknown.Material & Methods: All kidney transplants (KTs) from ≥65‐year‐old donors performed at our center from 1999 to 2018 (n = 185) were retrospectively analyzed and outcome was compared for KTs from donors with and without a history of CPR (n = 27 and n = 158, respectively).Results: No significant differences in the incidence of delayed graft function (DGF) as well as 1‐ and 3‐year graft function were observed between the CPR and the no‐CPR group (DGF: 26.0% vs. 31.0%, p = .76; 1‐year serum creatinine: 150.4 μmol/L vs. 177.0 μmol/L, p = .11; 3‐year serum creatinine: 150.4 μmol/L vs. 168.2 μmol/L, p = .52, respectively). Death‐censored graft survival was comparable after 1 and 5 years (CPR group: 81.5% and 76.7% vs. no‐CPR group: 86.6% and 75.7%, p = .70). Likewise, patient survival was not significantly different. Multivariable Cox regression analysis also did not identify CPR as a significant risk factor for graft loss or death.Conclusion: Our study suggests that, following stringent donor selection, the outcome of KTs from ≥65‐year‐old braindead donors with and without a history of CPR is comparable.